LexaGene (LXXGF) Stock Price, News & Analysis

Company Overview

LexaGene Inc. is a biotechnology company that developed automated molecular diagnostic systems for the rapid detection of pathogens and other genetic targets. Its technology was designed to combine sample preparation, multiplex polymerase chain reaction (PCR) testing and analysis in a single workflow.

The company’s principal product was the MiQLab System, a compact, cartridge-based platform intended to provide sample-to-answer testing. LexaGene developed assays for applications including veterinary diagnostics, infectious disease testing, animal health, aquaculture and food safety. The system was designed to test for multiple pathogens simultaneously, with the goal of providing results more quickly than conventional laboratory-based methods.

LexaGene was founded by Dr. Jack Regan, who served as a co-founder and chief executive officer. The company was based in North America and marketed its diagnostic technology primarily to veterinary practices, research organizations and other testing markets. Available public information primarily describes LexaGene’s historical development of the MiQLab platform and related diagnostic assays.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.42 million shs
• Average Volume: 318,206 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:LXXGF
• CIK: 1450416
• Web: www.lexagene.com
• Phone: 800 215 1824
• Fax: N/A
• Employees: 41
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A